Spironolactone in heart failure--a revived role for an old drug
- PMID: 11091472
- DOI: 10.1054/iccn.2000.1544
Spironolactone in heart failure--a revived role for an old drug
Abstract
Spironolactone is an aldosterone antagonist which has been used as a mild potassium-sparing diuretic and in treatment of ascites in liver failure. Recent studies have shown that it has an additive effect to those of ACE inhibitors in heart failure treatment.
Similar articles
-
Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).Am J Cardiol. 1996 Oct 15;78(8):902-7. doi: 10.1016/s0002-9149(96)00465-1. Am J Cardiol. 1996. PMID: 8888663 Clinical Trial.
-
[Decrease in mortality on spironolactone being added to the conventional treatment of heart failure].Aten Primaria. 2000 Mar 15;25(4):282-4. doi: 10.1016/s0212-6567(00)78503-9. Aten Primaria. 2000. PMID: 10795447 Free PMC article. Spanish. No abstract available.
-
[Therapy of heart failure after myocardial infarction. With eplerenone a new course].MMW Fortschr Med. 2004 Oct 21;146(43):58-9. MMW Fortschr Med. 2004. PMID: 15559524 German. No abstract available.
-
[Diuretic therapy in congestive heart failure--new views on spironolactone therapy].Ther Umsch. 2000 Jun;57(6):374-9. doi: 10.1024/0040-5930.57.6.374. Ther Umsch. 2000. PMID: 10894022 Review. German.
-
Aldosterone antagonism and congestive heart failure: a new look at an old therapy.Curr Opin Cardiol. 2004 Jul;19(4):301-8. doi: 10.1097/01.hco.0000129667.34622.14. Curr Opin Cardiol. 2004. PMID: 15218387 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous